To Örebro University

oru.seÖrebro University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Association between Microscopic Colitis and Parkinson's Disease in a Swedish Population
Med Epidemiol & Biostat, Solna, Sweden.
Med Epidemiol & Biostat, Solna, Sweden.ORCID iD: 0000-0002-5042-8326
Med Epidemiol & Biostat, Solna, Sweden.
Harvard Med Sch, Massachusetts Gen Hosp, Boston MA, USA.
Show others and affiliations
2021 (English)In: Neurology, ISSN 0028-3878, E-ISSN 1526-632X, Vol. 96, no 15 Suppl.Article in journal, Meeting abstract (Other academic) Published
Abstract [en]

Objective: To examine the association between microscopic colitis (MC) and Parkinson’s disease (PD) risk.

Background: Gastrointestinal inflammation has been linked with PD. MC is a chronic intestinal inflammatory disease; however, its relationship with PD is unknown.

Design/Methods: A population-based matched cohort study was conducted to estimate the association between MC and incident PD diagnosis using Cox regression models. An exposed cohort of 12,609 MC patients diagnosed 1990–2017 and aged ≥35 years at diagnosis was identified from the Epidemiology Strengthened by histoPathology Reports in Sweden cohort (ESPRESSO). Two unexposed cohorts were compared to: a population cohort comprising 58,879 MC-free individuals randomly selected from the population and 1:5 matched to each MC patient by age, sex, year of biopsy and county of residence at the time of biopsy; and a sibling cohort (NMC/NSibling=6,281/12,351) including all siblings of the MC patients. Follow-up was from the date of biopsy until December 31st 2016 at latest.

Results: During a mean follow-up of ~7 years, we identified 449 incident PD diagnoses among the MC patients and their matched population cohort. The overall PD risk was 76% higher among MC versus MC-free individuals; but the association attenuated substantially during follow-up. In the time-varying effects model, PD risk was 3.45-fold (95% CI: 2.42, 4.93) higher during the first 2 years after biopsy and 1.80-fold (95% CI: 1.23, 2.64) higher during the following 3 years among MC versus MC-free individuals, but was not differential beyond 5 years after biopsy (hazard ratio=1.03; 95% CI: 0.68, 1.54). This temporal pattern of MC-PD associations persisted in sibling analyses. Using a matched case-control design, we also observed a higher prevalence of prior PD diagnosis among MC patients than the matched MC-free individuals (odds ratio=3.46; 95% CI: 2.91, 4.12).

Conclusions: Our findings suggest that MC may not be a risk factor, but rather a comorbidity or complication of PD.

Place, publisher, year, edition, pages
Wolters Kluwer, 2021. Vol. 96, no 15 Suppl.
National Category
Neurology
Identifiers
URN: urn:nbn:se:oru:diva-96227ISI: 000729283600006OAI: oai:DiVA.org:oru-96227DiVA, id: diva2:1625495
Available from: 2022-01-07 Created: 2022-01-07 Last updated: 2022-01-07Bibliographically approved

Open Access in DiVA

No full text in DiVA

Authority records

Ludvigsson, Jonas F.

Search in DiVA

By author/editor
Ploner, AlexanderLudvigsson, Jonas F.
By organisation
School of Medical SciencesÖrebro University Hospital
In the same journal
Neurology
Neurology

Search outside of DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric score

urn-nbn
Total: 17 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf